Merck
CN
Search Within
Document Type

3605-96-7

Applied Filters:
Keyword:'3605-96-7'
Showing 1-6 of 6 results for "3605-96-7" within Technical Documents
User Protocol: Ultra-high temperature Ceramic (B4C) Ink for Direct-Ink Writing
921912?context=product 2/2 Figure 1: Phase diagram of B4C (J. Am. Ceram. Soc., 94 [11] 3605–3628 (2011)).
Product Information Sheet - E6888
product is also soluble in dimethylformamide.10 References 1. The Merck Index, 12th ed., Entry# 3605. 2. Martindale The Extra Pharmacopoeia, 31st ed., Reynolds, J. E. F., ed., Royal Pharmaceutical
User_Guide -HTS223RTA
Non-binding white plates (for ligand prep) 3605 (96-well)/3574 (384-well) (Corning) Black (clear bottom) tissue-culture treated plates 3904 (96-well)/3712 (384-well) (Corning) FLIPR Settings
ChemiScreen™ Calcium-Optimized Stable Cell Line Human Recombinant GPR109A Receptor
ligand addition at 10 seconds. 9. Ligands are prepared in a white nonbinding surface 96-well plate (Corning 3605). 10. After the run is complete, negative control correction is applied and data analyzed
ChemiScreen™ Calcium-Optimized Stable Cell Line Human Recombinant GPR39 Zinc Receptor
ligand addition at 10 seconds. 11. Ligands are prepared in a white nonbinding surface 96-well plate (Corning 3605). 12. After the run is complete, negative control correction is applied and data analyzed
ChemiScreen™ Calcium-Optimized Stable Cell Line Human Recombinant GPR91 Succinate Receptor
ligand addition at 10 seconds. 9. Ligands are prepared in a white nonbinding surface 96-well plate (Corning 3605). 10. After the run is complete, negative control correction is applied and data analyzed